Investigations on differences in atorvastatin metabolites ratios as a diagnostic tool in detecting atorvastatin induced myotoxicity.
Phase of Trial: Phase IV
Latest Information Update: 18 Aug 2009
At a glance
- Drugs Atorvastatin (Primary)
- Indications Lipid metabolism disorders
- Focus Pharmacokinetics
- 18 Aug 2009 Planned number of patients (53) added as reported by ClinicalTrials.gov.
- 18 Aug 2009 Planned end date changed from 1 Mar 2009 to 1 Jun 2009 Last checked against ClinicalTrials.gov record.
- 17 Jan 2007 New trial record.